Sildenafil Tablet, Film Coated
Product Images NDC 72789-103

Product Visual Gallery

This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Sildenafil (NDC 72789-103). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Pd-rx Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

72789103 Label (72789103)

Label for PD-Rx Pharmaceuticals Sildenafil USP 50 mg film-coated tablets. The label indicates a package size of 15 tablets and includes the NDC number 72789-103-15. It features dosage strength in a black box, reorder number, lot number G20D32, and expiration date 03/2022. The label includes bilingual dosage instructions and warnings to keep out of reach of children.*

FDA Label Image

Sildenafilfigure7 (Sildenafilfigure7)

A bar graph showing the percentage of patients reporting improvement across different treatment groups. The groups include Placebo and Sildenafil Citrate Tablets at doses of 25 mg, 50 mg, and 100 mg, with increasing percentages of reported improvement from placebo to the highest dose.*

FDA Label Image

Sildenafilfigure1 (Sildenafilfigure1)

A line graph comparing the effects of Sildenafil 100 mg and a placebo on systolic blood pressure (mmHg) over 24 hours post-dose. The x-axis represents time in hours, and the y-axis shows changes in systolic blood pressure. Two plotted lines indicate the blood pressure changes for Sildenafil and placebo groups over time.*

FDA Label Image

Sildenafilfigure2 (Sildenafilfigure2)

A line graph comparing two variables over time (hours) postdose. The x-axis represents time postdose from 0 to 8 hours, and the y-axis shows change in SBP (mmHg) ranging approximately from -40 to +20. Two lines represent different treatments: dopamine and placebo, and tomaxamit 25 mg, tracked over the time course with data points marked.*

FDA Label Image

Sildenafilfigure3 (Sildenafilfigure3)

A line graph showing the change in systolic blood pressure (%) over time in hours. It compares two groups: one treated with Placebo and the other with Sildenafil 50 mg, with separate lines and data points for each group.*

FDA Label Image

Sildenafilfigure4 (Sildenafilfigure4)

A line graph depicting mean change over time (in hours) after dosing, comparing two treatment groups: Doxazosin with Sildenafil 100 mg and Doxazosin with placebo. The y-axis shows the change in millimeters, and the x-axis represents time from 0 to 8 hours.*

FDA Label Image

Sildenafilfigure5 (Sildenafilfigure5)

Line graph depicting plasma concentration of a drug over 24 hours post-dose. The x-axis represents time in hours, and the y-axis shows plasma concentration in ng/mL. The curve labeled "Commercial Tablet" shows a peak concentration shortly after dosing, followed by a gradual decline over time.*

FDA Label Image

Sildenafilfigure6a (Sildenafilfigure6a)

A bar chart showing the percentage of patients at endpoint plotted against baseline scores. Multiple bars represent different grouped values ranging from 0 to 5, with the vertical axis displaying the percentage scale from 0 to 80%. This figure likely presents patient outcome distribution by baseline score categories.*

FDA Label Image

Sildenafilfigure6b (Sildenafilfigure6b)

A bar chart displaying the percentage of patients at endpoint across different baseline scores ranging from 0 to 5. The bars are segmented by categories labeled 00 through 5, each represented by different shading patterns. The x-axis shows baseline scores, while the y-axis indicates the percentage of patients at the endpoint.*

FDA Label Image

Sildenafilstructure (Sildenafilstructure)

Chemical structure diagram of sildenafil, showing its molecular composition including a sulfonamide group, a piperazine ring, and a pyrazolo[4,3-d]pyrimidin-7-one core.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.